CRLF2 and acute lymphoblastic leukemia: Notably, this threshold was much lower that the cut-point adopted for AIEOP BCP-ALL patients (20 times the median value), [19] indicating that T-ALL blast cells might be more sensitive to variation of CRLF2 expression.